Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung.

Mucinous adenocarcinoma of the lung is a subtype of highly invasive pulmonary tumors and is associated with decreased or absent expression of the transcription factor NK2 homeobox 1 (NKX2-1; also known as TTF-1). Here, we show that haploinsufficiency of Nkx2-1 in combination with oncogenic Kras(G12D), but not with oncogenic EGFR(L858R), caused pulmonary tumors in transgenic mice that were phenotypically similar to human mucinous adenocarcinomas. Gene expression patterns distinguished tumor goblet (mucous) cells from nontumorigenic airway and intestinal goblet cells. Expression of NKX2-1 inhibited urethane and oncogenic Kras(G12D)-induced tumorigenesis in vivo. Haploinsufficiency of Nkx2-1 enhanced Kras(G12D)-mediated tumor progression, but reduced EGFR(L858R)-mediated progression. Genome-wide analysis of gene expression demonstrated that a set of genes induced in mucinous tumors was shared with genes induced in a nontumorigenic chronic lung disease, while a distinct subset of genes was specific to mucinous tumors. ChIP with massively parallel DNA sequencing identified a direct association of NKX2-1 with the genes induced in mucinous tumors. NKX2-1 associated with the AP-1 binding element as well as the canonical NKX2-1 binding element. NKX2-1 inhibited both AP-1 activity and tumor colony formation in vitro. These data demonstrate that NKX2-1 functions in a context-dependent manner in lung tumorigenesis and inhibits Kras(G12D)-driven mucinous pulmonary adenocarcinoma.

[1]  H. Varmus,et al.  Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors. , 2006, Genes & development.

[2]  S. Hannenhalli,et al.  GATA and Nkx factors synergistically regulate tissue-specific gene expression and development in vivo , 2007, Development.

[3]  Humam Kadara,et al.  Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis , 2011, Clinical Cancer Research.

[4]  C. Mendelson,et al.  Permissive Effects of Oxygen on Cyclic AMP and Interleukin-1 Stimulation of Surfactant Protein A Gene Expression Are Mediated by Epigenetic Mechanisms , 2006, Molecular and Cellular Biology.

[5]  N. Heintz,et al.  Asbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways. , 2010, American journal of respiratory cell and molecular biology.

[6]  Y. Yatabe,et al.  Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1. , 2007, Cancer research.

[7]  Jurg Ott,et al.  Distribution and characterization of regulatory elements in the human genome. , 2002, Genome research.

[8]  H. Varmus,et al.  Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. , 2001, Genes & development.

[9]  Ping Wang,et al.  Thyroid transcription factor in differentiating type II cells: regulation, isoforms, and target genes. , 2007, American journal of respiratory cell and molecular biology.

[10]  J. Locker,et al.  Loss of Nkx2.8 deregulates progenitor cells in the large airways and leads to dysplasia. , 2006, Cancer research.

[11]  A. Regev,et al.  SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas , 2009, Nature Genetics.

[12]  Kohei Miyazono,et al.  Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells. , 2009, Cancer research.

[13]  Ralph Weissleder,et al.  Effective Use of PI3K and MEK Inhibitors to Treat Mutant K-Ras G12D and PIK3CA H1047R Murine Lung Cancers , 2008, Nature Medicine.

[14]  C. Basbaum,et al.  MUC5AC mucin gene regulation in pancreatic cancer cells. , 2006, International journal of oncology.

[15]  U. Pastorino,et al.  Functional FGFR4 Gly388Arg polymorphism predicts prognosis in lung adenocarcinoma patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  S. Tomida,et al.  MYBPH, a transcriptional target of TTF‐1, inhibits ROCK1, and reduces cell motility and metastasis , 2012, The EMBO journal.

[17]  P. Howarth,et al.  Airway epithelial transcription factor NK2 homeobox 1 inhibits mucous cell metaplasia and Th2 inflammation. , 2011, American journal of respiratory and critical care medicine.

[18]  A. Malkinson.  Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung. , 2001, Lung cancer.

[19]  D. Leroith,et al.  Insulin-like Growth Factors and Cancer , 1995, Annals of Internal Medicine.

[20]  J. Whitsett,et al.  Ectopic respiratory epithelial cell differentiation in bronchiolised distal airspaces in idiopathic pulmonary fibrosis , 2011, Thorax.

[21]  L. Owen-Schaub.  Fas function and tumor progression: use it and lose it. , 2002, Cancer cell.

[22]  M. Gallup,et al.  Tobacco Smoke Control of Mucin Production in Lung Cells Requires Oxygen Radicals AP-1 and JNK* , 2004, Journal of Biological Chemistry.

[23]  S. Henderson,et al.  Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6 , 2005, The EMBO journal.

[24]  G. Bepler,et al.  Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  B. Fingleton,et al.  Epithelial NF-κB activation promotes urethane-induced lung carcinogenesis , 2007, Proceedings of the National Academy of Sciences.

[26]  Kwon-Sik Park,et al.  SPDEF regulates goblet cell hyperplasia in the airway epithelium. , 2007, The Journal of clinical investigation.

[27]  S. Reddy,et al.  FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo. , 2007, Cancer research.

[28]  Derek Y. Chiang,et al.  Suppression of Lung Adenocarcinoma Progression by Nkx2-1 , 2011, Nature.

[29]  R. Lotan,et al.  Immunohistochemical Expression of Basic Fibroblast Growth Factor and Fibroblast Growth Factor Receptors 1 and 2 in the Pathogenesis of Lung Cancer , 2008, Clinical Cancer Research.

[30]  Richard Simon,et al.  A random variance model for detection of differential gene expression in small microarray experiments , 2003, Bioinform..

[31]  Abraham P. Fong,et al.  Genome-wide transcription factor binding: beyond direct target regulation. , 2011, Trends in genetics : TIG.

[32]  J. Subramanian,et al.  Molecular genetics of lung cancer in people who have never smoked. , 2008, The Lancet. Oncology.

[33]  I Petersen,et al.  Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer , 2008, Oncogene.

[34]  M. Tretiakova,et al.  Transgenic expression of the forkhead box M1 transcription factor induces formation of lung tumors , 2008, Oncogene.

[35]  Jude Kendall,et al.  Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer , 2007, Proceedings of the National Academy of Sciences.

[36]  S. Hodge,et al.  In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2. , 2006, Lung cancer.

[37]  J. Whitsett,et al.  Lung Cell-specific Expression of the Murine Surfactant Protein A (SP-A) Gene Is Mediated by Interactions between the SP-A Promoter and Thyroid Transcription Factor-1 (*) , 1995, The Journal of Biological Chemistry.

[38]  Tomoya Yamaguchi,et al.  NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma. , 2012, Cancer cell.

[39]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[40]  J. Ward,et al.  Role of NKX2-1 in N-bis(2-hydroxypropyl)-nitrosamine-induced thyroid adenoma in mice. , 2009, Carcinogenesis.

[41]  Christopher S. Law,et al.  Tonicity-dependent induction of Sgk1 expression has a potential role in dehydration-induced natriuresis in rodents. , 2009, The Journal of clinical investigation.

[42]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[43]  C H Fox,et al.  The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. , 1996, Genes & development.

[44]  K. O'Byrne,et al.  Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study. , 2011, The Lancet. Oncology.

[45]  Jeffrey A Whitsett,et al.  Transcriptional control of lung morphogenesis. , 2007, Physiological reviews.

[46]  Masahiro Tsuboi,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[47]  Thomas M. Harris,et al.  Both Gene Amplification and Allelic Loss Occur at 14q13.3 in Lung Cancer , 2010, Clinical Cancer Research.

[48]  J. Pollack,et al.  Immortalization of Human Bronchial Epithelial Cells in the Absence of Viral Oncoproteins , 2004, Cancer Research.

[49]  K. Kaestner,et al.  Foxa2 regulates alveolarization and goblet cell hyperplasia , 2004, Development.

[50]  Derek Y. Chiang,et al.  Characterizing the cancer genome in lung adenocarcinoma , 2007, Nature.

[51]  R. Lauro,et al.  The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis , 1994, Molecular and cellular biology.

[52]  J. Whitsett,et al.  Foxa2 Programs Th2 Cell-Mediated Innate Immunity in the Developing Lung , 2010, The Journal of Immunology.

[53]  J. Whitsett,et al.  Intersections between pulmonary development and disease. , 2011, American journal of respiratory and critical care medicine.

[54]  Susan E Wert,et al.  SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production. , 2009, The Journal of clinical investigation.

[55]  B. Aronow,et al.  Unique and overlapping gene expression patterns driven by IL-4 and IL-13 in the mouse lung. , 2009, The Journal of allergy and clinical immunology.

[56]  B. Fingleton,et al.  Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis. , 2007, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Bill B. Chen,et al.  F box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resulting in cell cycle arrest , 2011, Oncogene.

[58]  D. Neil Hayes,et al.  LKB1 modulates lung cancer differentiation and metastasis , 2007, Nature.